2025-11910Notice

Merck Sharp Dohme Gains FTZ Okay for New Jersey Pharma Research

Published Date: 6/27/2025

Notice

Summary

Merck, Sharp & Dohme LLC got the green light to make pharmaceutical products for research and development at their Rahway, New Jersey facility inside Foreign-Trade Zone 49. This means they can produce these products with special trade benefits, helping them save money and speed up their work. The approval was finalized on June 20, 2025, with no extra reviews needed.

No Economic Impacts Identified for this Document

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Effective Date
Published Date
6/20/2025
6/27/2025

Department and Agencies

Department
Independent Agency
Agency
Commerce Department
Foreign-Trade Zones Board
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register